Ruben D Houvast, Vincent Q Sier, Maurice van Duijvenvoorde, Victor M Baart, Timo Schomann, JiaXin Chua, Mireille Vankemmelbeke, Lindy G Durrant, Daniëlle Krijgsman, Pieter de Heer, Gert-Jan Hassing, J Sven D Mieog, A Stijn L P Crobach, Jacobus Burggraaf, Peter J K Kuppen, Alexander L Vahrmeijer, Cornelis F M Sier
{"title":"校正:甘聚糖靶向单克隆抗体用于胃肠道肿瘤的双峰近红外荧光和光声成像的临床前评估。","authors":"Ruben D Houvast, Vincent Q Sier, Maurice van Duijvenvoorde, Victor M Baart, Timo Schomann, JiaXin Chua, Mireille Vankemmelbeke, Lindy G Durrant, Daniëlle Krijgsman, Pieter de Heer, Gert-Jan Hassing, J Sven D Mieog, A Stijn L P Crobach, Jacobus Burggraaf, Peter J K Kuppen, Alexander L Vahrmeijer, Cornelis F M Sier","doi":"10.1186/s13550-025-01308-5","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11611,"journal":{"name":"EJNMMI Research","volume":"15 1","pages":"117"},"PeriodicalIF":3.1000,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12405107/pdf/","citationCount":"0","resultStr":"{\"title\":\"Correction: Preclinical evaluation of glycan-targeting monoclonal antibodies for bimodal near-infrared fluorescence and photoacoustic imaging of gastrointestinal cancers.\",\"authors\":\"Ruben D Houvast, Vincent Q Sier, Maurice van Duijvenvoorde, Victor M Baart, Timo Schomann, JiaXin Chua, Mireille Vankemmelbeke, Lindy G Durrant, Daniëlle Krijgsman, Pieter de Heer, Gert-Jan Hassing, J Sven D Mieog, A Stijn L P Crobach, Jacobus Burggraaf, Peter J K Kuppen, Alexander L Vahrmeijer, Cornelis F M Sier\",\"doi\":\"10.1186/s13550-025-01308-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":11611,\"journal\":{\"name\":\"EJNMMI Research\",\"volume\":\"15 1\",\"pages\":\"117\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-09-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12405107/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EJNMMI Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s13550-025-01308-5\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJNMMI Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13550-025-01308-5","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
Correction: Preclinical evaluation of glycan-targeting monoclonal antibodies for bimodal near-infrared fluorescence and photoacoustic imaging of gastrointestinal cancers.
EJNMMI ResearchRADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING&nb-
CiteScore
5.90
自引率
3.10%
发文量
72
审稿时长
13 weeks
期刊介绍:
EJNMMI Research publishes new basic, translational and clinical research in the field of nuclear medicine and molecular imaging. Regular features include original research articles, rapid communication of preliminary data on innovative research, interesting case reports, editorials, and letters to the editor. Educational articles on basic sciences, fundamental aspects and controversy related to pre-clinical and clinical research or ethical aspects of research are also welcome. Timely reviews provide updates on current applications, issues in imaging research and translational aspects of nuclear medicine and molecular imaging technologies.
The main emphasis is placed on the development of targeted imaging with radiopharmaceuticals within the broader context of molecular probes to enhance understanding and characterisation of the complex biological processes underlying disease and to develop, test and guide new treatment modalities, including radionuclide therapy.